Triple-negative breast cancer (TNBC) is a subtype of breast cancer that accounts for about 15–20% of all breast cancers and is defined by tumors lacking estrogen receptor expression, progesterone receptor expression, and human epidermal growth factor receptor-2 (HER2) overexpression/amplification [1, 2]. Here, ERBB2 is linked to triple-negative breast carcinoma.